(2R,2'R,3S,3'S,4S,4'S,5R,5'R,6S,6'S)-6,6'-Oxybis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)

Catalog No. :
ACAACX014
CAS No. :
499-23-0
Molecular Formula :
C12H22O11
Molecular Weight :
342.30

IUPAC Name:(2R,2'R,3S,3'S,4S,4'S,5R,5'R,6S,6'S)-6,6'-oxybis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)

(2R,2'R,3S,3'S,4S,4'S,5R,5'R,6S,6'S)-6,6'-Oxybis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$603.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,2'R,3S,3'S,4S,4'S,5R,5'R,6S,6'S)-6,6'-Oxybis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
IUPAC Name(2R,2'R,3S,3'S,4S,4'S,5R,5'R,6S,6'S)-6,6'-oxybis(2-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
Molecular FormulaC12H22O11
Molecular Weight342.30
SMILESO[C@@H]1[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@H](O)[C@H]1O
InChI KeyHDTRYLNUVZCQOY-NCFXGAEVSA-N
SynonymSS,SSTREHALOSE;Isotrehalose, β-D-Glucopyranosyl β-D-glucopyranoside;Β-D-GLUCOPYRANOSYL Β-D-GLUCOPYRANOSIDE;B,B-TREHALOSE;BETA,BETATREHALOSE;β,β-[UL-13C12]trehalose;β,β-trehalose
CAS No.499-23-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAACX014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAACX014 route product structure diagram
    ACAACX014499-23-0
Inquiry

2. ACAACX014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAACX014 route product structure diagram
    ACAACX014499-23-0
Inquiry

Comments (0)